Delivering mRNA via acid-degradable nanoparticles offers a new frontier in prenatal gene editing, setting the stage for treatments targeting the root...
A CRISPR-Cas9 treatment reactivated a crucial gene in mice and human neurons — hinting at a possible one-time treatment for Angelman syndrome.
